Viewing Study NCT03141034


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-02-27 @ 10:02 AM
Study NCT ID: NCT03141034
Status: COMPLETED
Last Update Posted: 2024-06-25
First Post: 2017-04-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma
Sponsor: Washington University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 201704082
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View